{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:06:28Z","timestamp":1774382788822,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003200","name":"Kementerian Sains, Teknologi dan Inovasi","doi-asserted-by":"publisher","award":["700-2\/1\/LRGS\/5525500"],"award-info":[{"award-number":["700-2\/1\/LRGS\/5525500"]}],"id":[{"id":"10.13039\/501100003200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12896-018-0461-y","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T14:09:18Z","timestamp":1539266958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Proof of concept in utilizing in-trans surface display system of Lactobacillus plantarum as mucosal tuberculosis vaccine via oral administration in mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Anhar Danial","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeevanathan","family":"Kalyanasundram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Sabidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelene Ai-Lian","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raha","family":"Abdul Rahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7683-4760","authenticated-orcid":false,"given":"Khatijah","family":"Yusoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"461_CR1","volume-title":"Global Tuberculosis Report 2017. WHO\/HTM\/TB\/2017.23","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global Tuberculosis Report 2017. WHO\/HTM\/TB\/2017.23. Geneva: WHO; 2017."},{"key":"461_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-016-0595-5","volume":"14","author":"M Pareek","year":"2016","unstructured":"Pareek M, Greenaway C, Noori T, Munoz J, Zenner D. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med Central. 2016;14:48.","journal-title":"BMC Med Central"},{"key":"461_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/mt.2015.216","volume":"24","author":"L Zhang","year":"2016","unstructured":"Zhang L, Ru H, Chen F, Jin C, Sun R, Fan X, Guo M, Mai J, Xu W, Lin Q, Liu J. Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms. Mol Ther. 2016;24:398\u2013405.","journal-title":"Mol Ther"},{"key":"461_CR4","doi-asserted-by":"crossref","unstructured":"Delogu G, Fadda G. The quest for a new vaccine against tuberculosis. J Infect Dev. 2009;3","DOI":"10.3855\/jidc.99"},{"key":"461_CR5","first-page":"645","volume":"49","author":"M a a Sarhan","year":"2011","unstructured":"Sarhan M a a, Musa M, Zainuddin ZF. Cloning, protein expression and display of synthetic multi-epitope mycobacterial antigens on Salmonella typhi Ty21a cell surface. Indian J Exp Biol. 2011;49:645\u201353.","journal-title":"Indian J Exp Biol"},{"key":"461_CR6","first-page":"779","volume":"138","author":"T Mohan","year":"2013","unstructured":"Mohan T, Verma P, Rao DN. Novel adjuvants & delivery vehicles for vaccines development: a road ahead. Indian J MedRes. 2013;138:779\u201395.","journal-title":"Indian J MedRes"},{"key":"461_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrmicro1840","volume":"6","author":"JM Wells","year":"2008","unstructured":"Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol. 2008;6:349\u201362.","journal-title":"Nat Rev Microbiol"},{"issue":"4s","key":"461_CR8","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"Jan Holmgren","year":"2005","unstructured":"Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11","journal-title":"Nature Medicine"},{"key":"461_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","volume":"27","author":"E Badell","year":"2009","unstructured":"Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Winter N. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-\u03b3 producing T-cells. Vaccine. 2009;27:28\u201337.","journal-title":"Vaccine"},{"key":"461_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tube.2010.09.007","volume":"91","author":"D Hokey","year":"2011","unstructured":"Hokey D, Misra A. Aerosol vaccines for tuberculosis: a fine line between protection and pathology. Tuberculosis (Edinb). 2011;91:82\u20135.","journal-title":"Tuberculosis (Edinb)"},{"key":"461_CR11","doi-asserted-by":"crossref","unstructured":"Varma NRS, Toosa H, Foo HL, Alitheen NBM, Nor Shamsudin M, Arbab AS. Display of the viral epitopes on Lactococcus lactis: a model for food grade vaccine against EV71. Biotechnol Res Int. 2013;431315","DOI":"10.1155\/2013\/431315"},{"key":"461_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00253-010-3050-0","volume":"90","author":"H Moeini","year":"2011","unstructured":"Moeini H, Rahim RA, Omar AR, Shafee N, Yusoff K. Lactobacillus acidophilus as a live vehicle for oral immunization against chicken anemia virus. Appl Microbiol Biotechnol. 2011;90:77\u201388.","journal-title":"Appl Microbiol Biotechnol"},{"key":"461_CR13","first-page":"880","volume":"72","author":"A Steen","year":"2006","unstructured":"Steen A, Steen A, Buist G, Buist G, Kok J, Kok J, Leenhouts K. Novel surface display system for proteins on non-genetically modifed gram-positive bacteria. Society. 2006;72:880\u20139.","journal-title":"Society"},{"key":"461_CR14","doi-asserted-by":"crossref","unstructured":"Kuczkowska K, Kleiveland CR, Minic R, Moen LF, \u00d8verland L, Tj\u00e5land R, Eijsink VGH. Immunogenic properties of Lactobacillus plantarum producing surface-displayed Mycobacterium tuberculosis antigens. Appl Environ Microbiol. 2017;83","DOI":"10.1128\/AEM.02782-16"},{"key":"461_CR15","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","volume":"23","author":"J a M Langermans","year":"2005","unstructured":"Langermans J a M, Doherty TM, Vervenne R a W, van der Laan T, Lyashchenko K, Greenwald R, Andersen P. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine. 2005;23:2740\u201350.","journal-title":"Vaccine"},{"key":"461_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molimm.2014.06.007","volume":"62","author":"W Li","year":"2014","unstructured":"Li W, Deng G, Li M, Zeng J, Zhao L, Liu X, Wang Y. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice. Mol Immunol. 2014;62:86\u201395.","journal-title":"Mol Immunol"},{"issue":"1","key":"461_CR17","first-page":"8","volume":"2","author":"DA Lewinsohn","year":"2017","unstructured":"Lewinsohn DA, Swarbrick GM, Park B, Cansler ME, Null MD, Toren KG, Lewinsohn DM. Comprehensive definition of human immunodominant CD8 antigens in tuberculosis. Vaccine. 2017;2(1):8.","journal-title":"Vaccine"},{"key":"461_CR18","doi-asserted-by":"publisher","first-page":"e72745","DOI":"10.1371\/journal.pone.0072745","volume":"8","author":"Q Xin","year":"2013","unstructured":"Xin Q, Niu H, Li Z, Zhang G, Hu L, Wang B, Li J, Yu H, Liu W, Da Z, Li R, Xian Q, Wang Y, Zhang Y, Jing T, Ma X, Zhu B. Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice. PLoS One. 2013;8:e72745.","journal-title":"PLoS One"},{"key":"461_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijmm.2008.01.012","volume":"298","author":"G Nagy","year":"2008","unstructured":"Nagy G, Emo\u201ddy L, P\u00e1l T. Strategies for the development of vaccines conferring broad-spectrum protection. Int J Med Microbiol. 2008;298:379\u201395.","journal-title":"Int J Med Microbiol"},{"key":"461_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1475-2859-12-115","volume":"12","author":"L Piubelli","year":"2013","unstructured":"Piubelli L, Campa M, Temporini C, Binda E, Mangione F, Amicosante M, Pollegioni L. Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins. Microb Cell Factories. 2013;12:115.","journal-title":"Microb Cell Factories"},{"key":"461_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Bio Bioeng. 2005;99:303\u201310.","journal-title":"J Bio Bioeng"},{"key":"461_CR22","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10295-012-1105-1","volume":"39","author":"VG Francis","year":"2012","unstructured":"Francis VG, Majeed MA, Gummadi SN. Recovery of functionally active recombinant human phospholipid scramblase 1 from inclusion bodies using N-lauroyl sarcosine. J Ind Microbiol Biotechnol. 2012;39:1041\u20138.","journal-title":"J Ind Microbiol Biotechnol"},{"key":"461_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pep.2013.09.005","volume":"92","author":"SA Mir","year":"2013","unstructured":"Mir SA, Sharma S. Cloning, expression and N-terminal formylation of ESAT-6 of Mycobacterium tuberculosis H37Rv. Protein Expr Purif. 2013;92:223\u20139.","journal-title":"Protein Expr Purif"},{"key":"461_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11095-009-9995-y","volume":"27","author":"S Shi","year":"2010","unstructured":"Shi S, Yu L, Sun D, Liu J, Hickey AJ. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis. Pharm Res. 2010;27:224\u201334.","journal-title":"Pharm Res"},{"key":"461_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2859-7-34","volume":"7","author":"S Peternel","year":"2008","unstructured":"Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Factories. 2008;7:34.","journal-title":"Microb Cell Factories"},{"key":"461_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2144\/000113304","volume":"48","author":"H Tao","year":"2010","unstructured":"Tao H, Liu W, Simmons BN, Harris HK, Cox TC, Massiah M. Purifying natively folded proteins from inclusion bodies using sarkosyl, triton X-100, and CHAPS. BioTechniques. 2010;48:61\u20134.","journal-title":"BioTechniques"},{"key":"461_CR27","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1128\/AEM.01227-12","volume":"78","author":"L Fredriksen","year":"2012","unstructured":"Fredriksen L, Kleiveland CR, Olsen Hult LT, Lea T, Nygaard CS, Eijsink VGH, Mathiesen G. Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-\u03baB in monocytes. Appl Environ Microbiol. 2012;78:5864\u201371.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"461_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00253-004-1851-8","volume":"68","author":"A. R. Raha","year":"2005","unstructured":"Raha AR, Varma NR, Yusoff K, Ross E, Foo HL. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl Microbiol Biotechnol. 2005;68 https:\/\/doi.org\/10.1007\/s00253-004-1851-8 .","journal-title":"Applied Microbiology and Biotechnology"},{"key":"461_CR29","first-page":"1042","volume":"35","author":"I Poquet","year":"2000","unstructured":"Poquet I, Saint V, Seznec E, Simoes N, Bolotin A, Gruss A. HtrA is the unique surface housekeeping protease in Lactococcus lactis and is required for natural protein processing. MolMicrob. 2000;35:1042\u201351.","journal-title":"MolMicrob"},{"key":"461_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/17425247.3.6.747","volume":"3","author":"EC Lavelle","year":"2006","unstructured":"Lavelle EC, O\u2019Hagan DT. Delivery systems and adjuvants for oral vaccines. Expert Opin Drug Deliv. 2006;3:747\u201362.","journal-title":"Expert Opin Drug Deliv"},{"key":"461_CR31","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1586\/14760584.2014.936852","volume":"13","author":"N Marasini","year":"2014","unstructured":"Marasini N, Skwarczynski M, Toth I. Oral delivery of nanoparticle-based vaccines. Expert Rev Vaccines. 2014;13:1361\u201376.","journal-title":"Expert Rev Vaccines"},{"key":"461_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1203\/00006450-200206000-00015","volume":"51","author":"H Qiao","year":"2002","unstructured":"Qiao H, Duffy LC, Griffiths E, Dryja D, Leavens A, Rossman J, Locniskar M. Immune responses in rhesus rotavirus-challenged Balb\/c mice treated with bifidobacteria and prebiotic supplements. Pediatr Res. 2002;51:750\u20135.","journal-title":"Pediatr Res"},{"key":"461_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.intimp.2010.03.014","volume":"10","author":"D Ghadimi","year":"2010","unstructured":"Ghadimi D, de Vrese M, Heller KJ, Schrezenmeir J. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium. Int Immunopharmacol. 2010;10:694\u2013706.","journal-title":"Int Immunopharmacol"},{"key":"461_CR34","doi-asserted-by":"publisher","first-page":"e47244","DOI":"10.1371\/journal.pone.0047244","volume":"7","author":"MJ Smelt","year":"2012","unstructured":"Smelt MJ, de Haan BJ, Bron P a, van Swam I, Meijerink M, Wells JM, de Vos P. L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner. PLoS One. 2012;7:e47244.","journal-title":"PLoS One"},{"key":"461_CR35","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/j.1365-2222.2005.02375.x","volume":"35","author":"LEM Niers","year":"2005","unstructured":"Niers LEM, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NOP, Knol EF, Hoekstra MO. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy. 2005;35:1481\u20139.","journal-title":"Clin Exp Allergy"},{"key":"461_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1067\/mai.2002.128528","volume":"110","author":"P Pochard","year":"2017","unstructured":"Pochard P, Gosset P, Grangette C, Andre C, Tonnel A-B, Pestel J, Mercenier A. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol. 2017;110:617\u201323.","journal-title":"J Allergy Clin Immunol"},{"key":"461_CR37","first-page":"55","volume":"3","author":"F Scaldaferri","year":"2013","unstructured":"Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Bo\u0161koski I, Gasbarrini A. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int. 2013;3:55\u201364.","journal-title":"Biomed Res Int"},{"key":"461_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0168-1656(98)00100-X","volume":"64","author":"OP Kuipers","year":"1998","unstructured":"Kuipers OP, De Ruyter PGGA, Kleerebezem M, De Vos WM. Quorum sensing-controlled gene expression in lactic acid bacteria. J Biotechnol. 1998;64:15\u201321.","journal-title":"J Biotechnol"},{"issue":"3","key":"461_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1128\/CVI.00299-06","volume":"14","author":"NG Cortes-Perez","year":"2007","unstructured":"Cortes-Perez NG, Ah-Leung S, Bermudez-Humaran LG, Corthier G, Wal JM, Langella P, Adel-Patient K. Intranasal co-administration of live lactococci producing interleukin-12 and a major cow\u2019s milk allergen inhibits allergic reaction in mice. Clin Vaccine Immunol. 2007;14(3):226\u201333.","journal-title":"Clin Vaccine Immunol"},{"key":"461_CR40","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.vaccine.2011.12.088","volume":"30","author":"D S\u00e1ez","year":"2012","unstructured":"S\u00e1ez D, Fern\u00e1ndez P, Rivera A, Andrews E, O\u00f1ate A. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity. Vaccine. 2012;30:1283\u201390.","journal-title":"Vaccine"},{"key":"461_CR41","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1016\/j.vaccine.2012.07.004","volume":"30","author":"F Hugentobler","year":"2012","unstructured":"Hugentobler F, Di Roberto RB, Gillard J, Cousineau B. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB\/c mice against Leishmania major infection. Vaccine. 2012;30:5726\u201332.","journal-title":"Vaccine"},{"key":"461_CR42","doi-asserted-by":"publisher","first-page":"1633 LP","DOI":"10.1542\/peds.2008-3645","volume":"124","author":"ME Pichichero","year":"2009","unstructured":"Pichichero ME. Booster Vaccinations: Can immunologic memory outpace disease pathogenesis? Pediatrics. 2009;124:1633 LP\u20131641.","journal-title":"Pediatrics"},{"key":"461_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","volume":"30","author":"V Pavot","year":"2012","unstructured":"Pavot V, Rochereau N, Genin C, Verrier B, Paul S. New insights in mucosal vaccine development. Vaccine. 2012;30:142\u201354.","journal-title":"Vaccine"},{"key":"461_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.plasmid.2014.05.003","volume":"74","author":"MST Maidin","year":"2014","unstructured":"Maidin MST, Song AA-L, Jalilsood T, Sieo CC, Yusoff K, Rahim RA. Construction of a novel inducible expression vector for Lactococcus lactis M4 and Lactobacillus plantarum Pa21. Plasmid. 2014;74:32\u20138.","journal-title":"Plasmid"},{"key":"461_CR45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/AEM.29.6.807-813.1975","volume":"29","author":"BE Terzaghi","year":"1975","unstructured":"Terzaghi BE, Sandine WE. Improved medium for lactic streptococci and their bacteriophages. Appl Microbiol. 1975;29:807\u201313.","journal-title":"Appl Microbiol"},{"key":"461_CR46","first-page":"2","volume-title":"Physiology of the Bacterial Cell: A Molecular Approach. Biochem Educ","author":"C Frederick","year":"1990","unstructured":"Frederick C, Neidhardt, Ingraham MS JL. Physiology of the Bacterial Cell: A Molecular Approach. Biochem Educ; 1990. p. 2."},{"key":"461_CR47","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1128\/IAI.68.10.5509-5516.2000","volume":"68","author":"NK Childers","year":"2000","unstructured":"Childers NK, Miller KL, Tong G, Llarena JC, Greenway T, Ulrich JT, Michalek SM. Adjuvant activity of monophosphoryl lipid a for nasal and oral immunization with soluble or liposome-associated antigen. Infect Immun. 2000;68:5509\u201316.","journal-title":"Infect Immun"},{"key":"461_CR48","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1086\/444425","volume":"192","author":"B Corth\u00e9sy","year":"2005","unstructured":"Corth\u00e9sy B, Boris S, Isler P, Grangette C, Mercenier A. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis. 2005;192:1441\u20139.","journal-title":"J Infect Dis"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-018-0461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12896-018-0461-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-018-0461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T21:26:58Z","timestamp":1605216418000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-018-0461-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1186\/s12896-018-0461-y","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"4 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animals were sourced, housed and treated in accordance with institutional guidelines approved by the Institutional Animal Care and Use Committee, Universiti Putra Malaysia (UPM\/IACUC\/AUP - R072\/2014).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"63"}}